Finerenone is a non-steroidal mineralocorticoid receptor antagonist used as an active pharmaceutical ingredient. It is supplied as a pharmaceutical raw material for the manufacturing of medications indicated to reduce the risk of kidney function decline, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes, as well as for heart failure with reduced ejection fraction.
Область применения: Информация на этой странице относится к идентификации химических веществ и к контекстам промышленного снабжения, исследований и производства. Она не является терапевтическим заявлением, медицинской рекомендацией или инструкцией по применению лекарственных средств.
Закупаете или поставляете это соединение?
Разместите инвентарь или запрос на покупку
CAS 1050477-27-4
4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid
pharmaceutical intermediate for finerenone
(S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic Acid
Pharmaceutical intermediate for finerenone
(4R)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxylic acid
n.a
5-Desethoxy,-5-Methoxy-Finerenone
Mineralocorticoid receptor antagonist intermediate
Долутегравир
HIV-1 integrase inhibitor
DOLUTEGRAVIR SODIUM
active pharmaceutical ingredient
7-methyl-2-(2,2,3,3-tetradeuteriocyclopropyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
active pharmaceutical ingredient
Tetrabutylammonium acetate
Phase transfer catalyst
4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide
BTBHLEZXCOBLCY-UHFFFAOYSA-N
CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C